Selected transcripts were validated by RT-qPCR in a separate cohort, confirming the downregulation of HOTAIR and PTGS2 in BCR::ABL1 high-expression Brazilian CML patients. The gene discussed is PTGS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.